![](https://investorshub.advfn.com/uicon/756666.png?cb=1598094430)
Tuesday, October 13, 2020 3:56:30 PM
Also, one of NeuroRX team members has recently advised DR. Hahn (head of the fda) on how to handle political fallout with other drugs, we have Congressman Andy Harris sitting on our data monitoring committee, some of the board members are former execs from Pfizer, Lilly and Johnson & Johnson, other board members are experts with FDA approvals, and our new CFO hired the other day is an expert in FDA regulatory strategies.
All of those reputations would not be jeopardized by misrepresenting some data. This is real... its really happening.
(I am not a professional advisor. Please seek professional advice prior to investing or trading in any securities.)
Disclaimer: I am not a professional advisor. Seek professional advice before investing or trading. I take risky positions and do not advise anyone to follow my opinions or actions.
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM